| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Humer Kristian | Chief Financial Officer | 500 TECHNOLOGY SQUARE, SUITE 700, CAMBRIDGE | /s/ Michael LaCascia, Attorney-in-Fact for Kristian F. Humer | 17 Nov 2025 | 0001872280 |
Kristian Humer is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.
The Reporting Person resigned as Chief Financial Officer of Foghorn Therapeutics Inc., effective November 14, 2025. This Form 4 is being filed solely as a voluntary exit Form 4 indicating that no further reporting will be required of the Reporting Person.